Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hartmann

Showing results (301-310 of 472) with videos related to

Pageof 48
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumorsC Kollmannsberger, J Beyer, J P Droz, et al.
Acta Psychiatrica Scandinavica|May 19, 2011
The plant sterol brassicasterol as additional CSF biomarker in Alzheimer's diseaseT Vanmierlo, J Popp, H Kölsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2000
First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastasesC Kollmannsberger, C Nichols, M Bamberg, et al.
Viruses|August 28, 2025
SARS-CoV-2 Remdesivir Exposure Leads to Different Evolutionary Pathways That Converge in Moderate Levels of Drug ResistanceCarlota Fernandez-Antunez, Line A Ryberg, Kuan Wang, et al.
Journal of the National Cancer Institute|January 6, 2000
Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumorsJ T Hartmann, C R Nichols, J P Droz, et al.
British Journal of Cancer|January 10, 2008
Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trialO Nehls, H Oettle, J T Hartmann, et al.
Cancer|April 3, 2001
Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcomeC Bokemeyer, J P Droz, A Horwich, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 20, 2003
Extragonadal germ cell tumors: relation to testicular neoplasia and management optionsCarsten Bokemeyer, Jorg T Hartmann, Sophie D Fossa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysisJ T Hartmann, L Einhorn, C R Nichols, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study GroupJörg T Hartmann, Thomas Gauler, Bernd Metzner, et al.
Pageof 48

Showing results (301-310 of 472) with videos related to

Sort By:
Pageof 48
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumorsC Kollmannsberger, J Beyer, J P Droz, et al.
Acta Psychiatrica Scandinavica|May 19, 2011
The plant sterol brassicasterol as additional CSF biomarker in Alzheimer's diseaseT Vanmierlo, J Popp, H Kölsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2000
First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastasesC Kollmannsberger, C Nichols, M Bamberg, et al.
Viruses|August 28, 2025
SARS-CoV-2 Remdesivir Exposure Leads to Different Evolutionary Pathways That Converge in Moderate Levels of Drug ResistanceCarlota Fernandez-Antunez, Line A Ryberg, Kuan Wang, et al.
Journal of the National Cancer Institute|January 6, 2000
Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumorsJ T Hartmann, C R Nichols, J P Droz, et al.
British Journal of Cancer|January 10, 2008
Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trialO Nehls, H Oettle, J T Hartmann, et al.
Cancer|April 3, 2001
Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcomeC Bokemeyer, J P Droz, A Horwich, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 20, 2003
Extragonadal germ cell tumors: relation to testicular neoplasia and management optionsCarsten Bokemeyer, Jorg T Hartmann, Sophie D Fossa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysisJ T Hartmann, L Einhorn, C R Nichols, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study GroupJörg T Hartmann, Thomas Gauler, Bernd Metzner, et al.
Pageof 48